1) 池田俊也,白岩 健,五十嵐中・他.日本語版EQ-5D-5Lにおけるスコアリング法の開発.保健医療科学2015;64(1):47-55.
2) Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale:development and validation of the general measure. J Clin Oncol 1993;11(3):570-9.
3) Chow E, Hird A, Velikova G, et al. EORTC Quality of Life Group. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases:the EORTC QLQ-BM22. Eur J Cancer 2009;45(7):1146-52.
4) 佐藤威文,小林国彦,堀 泰祐・他.骨転移がん患者に対するEORTC QOL調査モジュール—EORTC QLQ-BM22日本語版の開発.癌と化学療法2010;37(8):1507-12.
5) Shinoda Y, Sawada R, Yoshikawa F, et al. Factors related to the quality of life in patients with bone metastases. Clin Exp Metastasis 2019;36(5):441-8.
6) Quraishi NA, Pasku D, Koch JEJ, et al. Prospective analysis of health-related quality of life after surgery for spinal metastases. Eur Spine J 2020;29(12):3163-9.
7) Choi D, Fox Z, Albert T, et al. Rapid improvements in pain and quality of life are sustained after surgery for spinal metastases in a large prospective cohort. Br J Neurosurg 2016;30(3):337-44.
8) van Tol FR, Suijkerbuijk KPM, Choi D, et al. The importance of timely treatment for quality of life and survival in patients with symptomatic spinal metastases. Eur Spine J 2020;29(12):3170-8.
9) Choi D, Fox Z, Albert T, et al. Prediction of quality of life and survival after surgery for symptomatic spinal metastases:a multicenter cohort study to determine suitability for surgical treatment. Neurosurgery 2015;77(5):698-708.
10) Miscusi M, Polli FM, Forcato S, et al. Comparison of minimally invasive surgery with standard open surgery for vertebral thoracic metastases causing acute myelopathy in patients with short- or mid-term life expectancy:surgical technique and early clinical results. J Neurosurg Spine 2015;22(5):518-25.